CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen

Clinical trial NCT00305838 · UNKNOWN

Trial details

NCT number: NCT00305838
Sponsor: Mount Vernon Cancer Centre at Mount Vernon Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 2004-03-01
Primary completion: 2008-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.